chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The next day after the vaccine, for 3 days I had muscle aches, extreme fatigue, and fever of 102. Muscle aches and fatigue went away but the fever continued for 10 days. I took Advil to bring down the fever. I talked with my doctor and had a negative COVID-19 test with a telehealth visit.
Since the vaccine was given, pain, redness continued for 1-2 week. Gradually redness gone, but still intermittent pain - it's been 20 days and still have slight black and blue and period pain feeling.
exposed to Covid19; she's had "mild" symptoms of a headache and being "sinus-y" and a low-grade fever of 99 F; she's had "mild" symptoms of a headache and being "sinus-y" and a low-grade feve of 99 F; This is a spontaneous report received from contactable consumer (patient). A 43-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: unknown) via an unspecified route of administration on 18Mar2021 (at the age of 43-year-old) as a single dose for COVID-19 immunization. Medical history and Concomitant medications were not reported. Family history included Covid-19 (patient 8 y/o daughter tested positive for Covid) on 31Mar2021. On 21Mar2021, patient was exposed to Covid19 at a family gathering with two people tested positive later that week. On 26Mar2021, she had a negative Covid test, but on the evening of 28Mar2021 her 8 y/o daughter started having Covid19 symptoms and later tested positive for Covid on 31Mar2021. Patient indicated that she's had "mild" symptoms of a headache and being "sinus-y" and a low-grade fever of 99F for one day in 2021, but she continued to test negative for Covid19 in 2021. Patient was due to receive her second dose of vaccine 08Apr2021. A member of the local health department told them to quarantine in their house until 19Apr2021. The outcome for the events mild" symptoms of a headache and being "sinus-y" and a low-grade fever of 99 F for one day was recovered on an unspecified date in 2021 and exposed to Covid19 was unknown.  No follow-up attempts are needed. No further information is expected.
On 04/01/2021 at about noon, I passed out and lost concsisness and hit my head on the floor. I had to go to the ER in which I spent for hours. I had to get a CT scan and a EKG done which came back fine. My blood levels showed my sodium was low. I was also put on a heart monitor for a month.
very mild tingling face. muscular changes in face during first 18 hours post vaccine. slightly fatigued day 2 slightly elevated heart rate during intense exercise days 3-4  Generally, however, I feel fine and plan to get the second dose!
the needle from the syringe of covid (pfizer) vaccine popped off and drops of liquid were seen on arm.  patient was not offered a correct re-injection.  Patient had a local vaccine reaction after first covid vaccine but had none after 2nd.
I received the vaccine around 1:30 pm on 2/17. At just after midnight in the early morning of 2/18, I awoke with with a stabbing left sided frontal headache (4/10) and diffuse itching from head to toe, including my throat. I only had a few (3) pinpoint lesions on my abdomen, I did not have trouble breathing and my oxygen saturation remained above 98% so I did not take Benadryl or feel the need to seek medical attention. The headache subsided the next day while the diffuse itching lasted a total of 3 days.
First Vaccine given on 1/27/2021. Pfizer. Lot: el9261. Site and route unknown
Patient complained of leg pain after vaccines but seemed appropriate given context - the next day parent noticed some redness and swelling of the left leg, which became much worse at the end of the day 11/09/2023.  Swelling reported entire thigh to knee, parents were advised to take patient to the ER for follow up.   He was administered benadryl and discharged home for follow up in office the next day.
Pt reported a history of syncope with injections and blood draws in the past. Shortly after injection, he passed out briefly. He was noted to be pale and diaphoretic on exam. Initial BP was 90/52 and this improved to 100/64 after several minutes. HR 78, SP02 99%. Pt improved with observation only. He drove himself home after 30+ minutes of observation after his symptoms completely resolved.
Initial report was received 18 October 2010 from a health care professional. A 40-year-old male patient with no concurrent illness and no past medical history, had received a right deltoid intramuscular injection of FLUZONE No Preservative 2010-2011, lot number U3563BA on 30 September 2010, and an unspecified amount of time later on the day of vaccination, he developed a fever (temperature not reported) and a headache. Over the next week, he developed bronchitis and was progressing to pneumonia. The patient was seen in the emergency room (date not reported); however, the reporter was unsure if the patient had been hospitalized. At the time of the report, symptoms had resolved and the patient was recovered (date of recovery not reported). Documents held by sender: None.
pt recv vax 1APR97 & it was reported that 2hr post vax pt exp redness, induration & warmth @ the site of inj;2 days post vax it was reported that the affected area was 4 inches in diameter;site appeared small, raised,non-tender area;
On October 9th came down with severe headache that has not gone away.  Symptoms include vertigo, dizziness, pain.  Seen primary care doctor, seen at urgent care 10/10/2022, Emergency Department on 10/10/2022 and 10/14/2022.  Seen by Dr on 10/12/22 Neurology.  Headache has not gone away.  Light and sound sensitive. Treated with imitrex 25-100mg/day, cyclobenzaprin 5mg, zofran 4mg, propranolol 40mg, butalbital, acetaminophen, caffeine, magnesium, compozine and toredol at hospital.
Syncope 5 minutes after injection with brief absence of respirations and pulse. Fully recovered during observation.
leukocytosis/ more than 4000 for white cells; This spontaneous case was reported by a pharmacist and describes the occurrence of LEUKOCYTOSIS (leukocytosis/ more than 4000 for white cells) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LEUKOCYTOSIS (leukocytosis/ more than 4000 for white cells). At the time of the report, LEUKOCYTOSIS (leukocytosis/ more than 4000 for white cells) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: 4000 white cells (Inconclusive) more than 4000 for white cells.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the reporter  No Treatment Information were provided by the reporter
Patient received flu shot (flucelvax) in left arm and started experiencing itchy and redness today 10/30.  Upon observation, there was a red, bumpy, circular spot about 3 inches in diameter on the patient's arm.  Denies any possible insect bites. No history of previous reaction to the flu vaccine. Patient is going to put Vaseline on it. Patient will monitor and ensure it does not get worse or spread. Patient is aware to seek medical care if it worsens or of any signs of infection.
Pt was administered DTaP in right thigh, Comvax in left thigh and MMR in left deltoid on 12/13/2001 at 4:30 PM, further reports right thigh and below swelled and turned red during night, warm to touch.
myalgia; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (myalgia) and PYREXIA (fever) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2021, the patient experienced MYALGIA (myalgia) and PYREXIA (fever). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. At the time of the report, MYALGIA (myalgia) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Fever 101.3 degrees F   This case was linked to MOD-2021-250232 (Patient Link).
Fever; Chills; Tiredness; Headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), FATIGUE (Tiredness) and HEADACHE (Headache) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jun-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), FATIGUE (Tiredness) and HEADACHE (Headache). On 18-Jun-2021, PYREXIA (Fever), CHILLS (Chills), FATIGUE (Tiredness) and HEADACHE (Headache) had resolved.            No concomitant medications were reported. No treatment information was provided by the reporter.    This case was linked to MOD-2021-231341 (Patient Link).
axillary lymphadenopathy;erythema, baggy edema of entire arm;erythema baggy edema from shoulders to elbow;
extreme fatigue; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2020, the patient received the 1st dose of Shingrix. In October 2020, 8 hrs after receiving Shingrix, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was recovered/resolved.   It was unknown if the reporter considered the fatigue to be related to Shingrix.  Additional details were reported as follows: The reporter was patient's wife. The patient experienced extreme fatigue which reporter described as negative symptoms.   The reporter stated that the fatigue started 8 hours after the vaccination in the patient's right arm and resolved after 12 hours. The reporter did not consent to follow-up. For tolerance of 2nd dose refer case US2021AMR039223.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021044017:same reporter US-GLAXOSMITHKLINE-US2021AMR039223:same reporter,same patient, same vaccine, different dose (1st dose)
Headache; This is a spontaneous report from a contactable consumer (patient herself). A 76-year-old female patient received first dose of pneumococcal 13-val conj vac (Dipht CRM197 Protein) (Unspecified trade name, Formulation: Solution for injection in pre-filled syringe), via an unspecified route of administration on an unspecified date as a single dose for immunization. The patient's medical history included obesity, endocrine abnormalities (including diabetes), genetic / chromosomal abnormalities, respiratory illness, compromised immune status, allergic to an unknown preservatives (unknown preservatives allergy gives her headaches), stress related to work. They used to be stress related to work and she retired. Concomitant medications were not reported. No previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). The patient did not receive additional vaccines on same date of the Pfizer suspect. No emergency room or physician's office required. The patient did not have prior vaccinations (within 4 weeks). Family medical history was none. She has had headache with Pneumonia vaccine, fast foods, and foods with sauces etc. They have never been able to determine the point of origin. She did not have the manufacturer for the Pneumonia vaccine she received and did not have a lot or expiration. It was 4 years ago. She never received the second Pneumonia 13 because of the reaction with the first one. Pneumonia shot first one and she had bad reactions, so she did not get the Pneumonia 13 since she had that. No manufacturer, lot, or expiration. It occurred around 4 years ago. They are telling her they are changing the Pneumonia vaccine so she has to talk to her doctor to see if she should try it again. The patient experienced headache on an unspecified date. She has not had a headache in a long time and that was why she feels it was the shot. No relevant tests included. The outcome of the event was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained. No further information is expected.
1st dose Moderna/2nd dose Pfizer; Revaccination with different COVID-19 vaccine; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (1st dose Moderna/2nd dose Pfizer), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002m21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (1st dose Moderna/2nd dose Pfizer), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (1st dose Moderna/2nd dose Pfizer), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INTERCHANGE OF VACCINE PRODUCTS (1st dose Moderna/2nd dose Pfizer) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine).    The concomitant medication was not reported by reporter. On 27-Sep-2021, patient received Pfizer Biontech Covid-19 Vaccine as a second dose, batch number FF8841 for an unknown indication. On 30-Sep-2022, patient received Pfizer Biontech Covid-19 Vaccine as a 4th dose Pfizer bivalent, batch number GJ5342 for an unknown indication. The treatment medication was not reported by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-714740 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-714740:Bivalent Dose Case
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Jan-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Jan-2022; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Jan-2022) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2022 at 3:30 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 31-Jan-2022 at 3:30 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Jan-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Jan-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Jan-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided.  A patient was administered vaccine past its 30 days expiry date vaccine went into 2 to 8 Celsius thaw state on or about to 24-Dec-2021, this vaccine administered was until its manufacturing (Mfg) expiration date of 04-Apr-2022.  No treatment medication information provided.
- Swollen face - headache - area of injection raised and iches and sore Txt - steroid, antihistamine
I experienced changes to the menstrual cycle following vaccination.  I'm not sure if it's vaccine related but I feel it's important to track if it is related.  My cycle is a regular 26-28 day cycle and has been regular for nearly 20 years.  I received the vaccine on 3/15/21 and I should have started menstruation on or around 3/20/21.  Instead, I was two weeks late with no other reason for being late and started my cycle on 4/6/21. I did take a pregnancy test to rule out pregnancy when I was 10 days late and it came back negative and at 14 days late my period started.  It was lighter than normal. I did go ahead and receive the second COVID immunization not really knowing if any connection was with the vaccination and reproductive cycle and there was no change following the second other than a lighter cycle following my second dose.
flushing with redness; flushing with redness; small hives on my face and neck; still have a small visible rash on my forehead; This is a spontaneous report from a contactable other hcp. A 51-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: EW0182), via an unspecified route of administration, administered in Arm Right on 08May2021 01:30 (at the age of: 51-years-old) as dose 1, single for covid-19 immunisation. Pregnant at Time of Vaccination was reported as No. Medical history included asthma, polycystic ovaries, metabolic syndrome and hypertension from an unknown date and unknown if ongoing. The patient is allergic to Latex and Hydrochlorothiazide. Concomitant medication(s) included ergocalciferol (VIT D); ascorbic acid, biotin, calcium carbonate, calcium pantothenate, chromium nicotinate, colecalciferol, cupric oxide, cyanocobalamin, ferrous fumarate, folic acid, magnesium hydroxide, manganese gluconate, nicotinamide, phytomenadione, potassium iodide, pyridoxine hydrochloride, retinol, riboflavin, selenomethionine, sodium molybdate, thiamine hydrochloride, tocopheryl acetate, zinc gluconate (MULTIVITAMIN FOR WOMEN) and trametes versicolor (TURKEY TAIL MUSHROOM) taken for an unspecified indication, start and stop date were not reported, received within 2 weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to covid vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was reported that she had Mod-Sev Asthma, so brought her EpiPen with her just in case. she did not have any breathing problems. However, at approx 30 mins post inj on 08May2021 12:00 PM she experienced flushing with redness and small hives on her face and neck. This resolved in about 10 mins, but recurred intermittently for a few hours, though each time it decreased in intensity and duration. she still have a small visible rash on her forehead. The patient did not receive any other treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovered/resolved with Sequel on an unspecified date in 2021.  Follow-up attempts completed. No further information expected.
1-2 hives on face near mouth (outside)  scratchy, dry throat  ER doctor had the nurse administer a steriod shot (methylPREDISolone (Medrol (pak)) and I was given famotidine (Pepcid pill).  A prescription was called into my pharmacy (famotidine and methylPREDNISolone)
Diffuse myalgias and muscle weakness. Pt had difficulty climbing stairs and felt like he might fall backwards. Towards end of his work day, his hands became too weak to manipulate instrument controls. Upon climbing into a van his legs felt weak and he had difficulty, and felt he might fall backwards. He did not receive any specific therapy. His symptoms gradually improved and had resolved (or nearly so) by 2/2/2017.
broke out with blister after first; This case was reported by a other health professional via interactive digital media and described the occurrence of blister in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced blister. On an unknown date, the outcome of the blister was unknown.   It was unknown if the reporter considered the blister to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. The patient experienced blisters after receiving Shingrix and asked if it was common.
Diarrhea during the night. Complete regression on potty training and occasional diarrhea during the day.
Significant and persistent fatigue, muscle weakness in legs as exhibited by patient's significant reduction in stamina and strength while riding a bicycle. Patient exhibited strength and stamina in riding a bicycle prior to his third COVID-19 vaccination with the Pfizer Bivalent vaccine.  Patient reports onset of leg weakness following vaccination with Pfizer Bivalent COVID-19 vaccination was gradual over two weeks subsequent to the vaccination, and persisting thereafter.  Patient has ridden his bicycle in this area for 15 years, and patient has been riding a bicycle for his entire life, since being able to first ride.
Red, Swelling, warm around area of vaccination, approximately 2x3 inches in size. Patient reports difficulty moving arm for approximately 2-3 days after vaccination.
47yo obese female h/o Asthma ambulated into the ED c/o severe allergy to the Moderna Vaccine which she received 40minutes ago. Patient state, she was advise about the risk and side effects of the vaccine. Patient state, she noticed nothing initial, then suddenly chest tightness, itching to the face, hoarseness, and wheezing. Patient state, she called the hotline for advise and advise to use her asthma inhaler and go to the nearest ED. Patient state, she received 40 of prednisone prior to receiving the Moderna vaccine in the left arm.  47yo female is in no acute distress. Patient symptoms resolving. Patient has no hoarseness or difficulty swallowing. Patient has no itchiness or respiratory distress. Patient chest xray shows no acute findings. Patient will continue with medication as prescribed. patient will be discharge home.